Today’s tickers: VNDA, PFE, S, ZION, GDX, PBR, BSX, AIG & PEP
VNDA – Vanda Pharmaceuticals, Inc. – The biopharmaceutical company, which specializes in the development of drug candidates for central nervous system disorders, attracted covered call selling in afternoon trading. It looks like one bullish individual purchased shares of the underlying stock in combination with the sale of 10,000 calls at the September $12.5 strike for an average premium of $1.13 per contract. Vanda’s shares – at the time of the transaction – were trading at $10.80 apiece. Thus, the investor effectively paid a net $9.67 per share because of the financing provided by the sale of the call options. The covered call strategy positions the investor to accumulate maximum potential profits of 29.25% if Vanda’s shares rally above $12.50 by expiration in September. This is because the short call stance provides an exit strategy for the trader which dictates gains of 29.25% on the appreciation in value of the underlying shares from the purchase price of $9.67 up to the $12.50 price at which the shares will be called from him – should the calls land in-the-money – at expiration in seven months. Vanda is scheduled to reveal its fourth-quarter earnings report before the opening bell on Tuesday February 16, 2010.
PFE – Pfizer, Inc. – Shares of the global pharmaceutical company commenced the current session in the red, but rallied in afternoon trading, rising 0.85% to $17.89 with forty-five minutes remaining in the trading day. Long-term optimistic trading patterns emerged in the January 2012 contract where one investor initiated a bullish risk reversal on the stock. It looks like the trader sold 5,000 puts at the January 2012 $17.5 strike for a premium of $3.20 each in order to purchase 5,000 calls at the same strike for $2.60 apiece. The investor pockets a net credit of $0.60 per contract on the reversal play, which he keeps in his piggy bank if Pfizer’s shares trade above $17.50 through January 2012 expiration. Additional profits amass to the upside as shares increase above the stated strike price of $17.50.
S – Sprint Nextel Corp. – Massive strangles plays on the communications company today indicate investors expect shares of the underlying stock to remain range-bound through expiration in May. Sprint’s shares fell significantly yesterday afternoon and continued lower by 2% to $3.28 today following disappointing fourth-quarter sales, which fell 6.7% to $7.87 billion. The third-largest U.S. wireless…
